Ivan Mishanin is the co-founder and COO of Brainify.AI, an AI/ML biomarker platform for novel treatment development aimed at female depression

Revolutionizing Depression Treatment: Embracing Opportunities in Challenging Times

04.06.2023 10:56 AM

In this article, we'll take you on a journey through the world of depression treatment development, exploring the challenges and opportunities that lie ahead. From the rising costs of creating new treatments to the cautious approach of the pharmaceutical industry, we'll delve into the complexities of this field and uncover how innovative approaches and collaborations can reshape the future of mental health care.

Most Popular

SpaceX Fired Up 33‑Engine Starship 'V3' Prototype for Testing, Marking a Major Step Toward Full‑Scale Orbital Flight

New Study Suggests Uranus and Neptune May Be Rock‑Dominated Rather Than Ice‑Rich

Engineered Blood Clots Stop Severe Bleeding in Seconds Using Synthetic Particles

Hantavirus Spreads Among Humans but Pandemic Risk Remains Low, Experts Say

How Deep Sea Creatures Use Bioluminescence Through Luciferin and Light Producing Chemistry